HCPCS Level II drug code
J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
In short
J7682 is the HCPCS Level II code for tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams. CMS assigns NDCs for Bethkis, Kitabis PAK, Tobi and Tobramycin and 1 more to it. One billing unit is 300 milligrams. The Medicare Part B payment limit is $11.404 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- Short descriptor
- Tobramycin non-comp unit
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2007
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J7682
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 22 NDCs to J7682 for Bethkis, Kitabis PAK, Tobi, Tobramycin and Tobramycin inhalation. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Bethkis | 10122-0820-28 | Chiesi USA, Inc. | 28 × 4 | 28 |
| Bethkis | 10122-0820-56 | Chiesi USA, Inc. | 56 × 4 | 56 |
| Kitabis PAK | 24492-0850-56 | PARI Respiratory Equipment | 56 × 5 | 56 |
| Tobi | 49502-0345-73 | Viatris Specialty LLC | 56 × 5 | 56 |
| Tobramycin | 00093-3750-28 | Teva Pharmaceuticals USA, Inc. | 28 × 4 | 28 |
| Tobramycin | 00093-3750-63 | Teva Pharmaceuticals USA, Inc. | 56 × 4 | 56 |
| Tobramycin | 66993-0195-94 | Prasco Laboratories | 56 × 4 | 56 |
| Tobramycin | 70756-0617-56 | Lifestar Pharma | 56 × 4 | 56 |
| Tobramycin inhalation | 00093-4085-63 | Teva Pharmaceuticals USA, Inc. | 56 × 5 | 56 |
| Tobramycin inhalation | 16714-0119-03 | Northstar RxLLC | 56 × 5 | 56 |
| Tobramycin inhalation | 42571-0408-92 | Micro Labs Limited | 56 × 5 | 56 |
| Tobramycin inhalation | 43598-0605-56 | Dr. Reddy's Laboratories Inc. | 56 × 5 | 56 |
| Tobramycin inhalation | 43598-0605-58 | Dr. Reddy's Laboratories Inc. | 56 × 5 | 56 |
| Tobramycin inhalation | 47335-0171-49 | Sun Pharmaceutical Global FZE. | 56 × 5 | 56 |
| Tobramycin inhalation | 60687-0731-83 | American Health Packaging | 30 × 5 | 30 |
| Tobramycin inhalation | 65162-0914-46 | Amneal Pharmaceuticals, LLC | 56 × 5 | 56 |
| Tobramycin inhalation | 68180-0962-56 | Lupin Pharmaceuticals, Inc. | 56 × 5 | 56 |
| Tobramycin inhalation | 70644-0899-99 | Genericus, Inc. | 56 × 5 | 56 |
| Tobramycin inhalation | 70756-0604-56 | Lifestar Pharma | 56 × 5 | 56 |
| Tobramycin inhalation | 72603-0430-56 | Northstar RxLLC | 56 × 5 | 56 |
| Tobramycin inhalation | 72603-0630-56 | Northstar RxLLC | 56 × 4 | 56 |
| Tobramycin inhalation | 76204-0029-56 | Ritedose Pharmaceuticals, LLC | 56 × 5 | 56 |
J7682: common questions
- Is J7682 a CPT code?
- No. J7682 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7682?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 22 NDCs under J7682, for Bethkis, Kitabis PAK, Tobi, Tobramycin and Tobramycin inhalation. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7682?
- $11.404 per 300 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J7682?
- One unit of J7682 is 300 milligrams, as stated in the code's descriptor. Units to report = dose given ÷ 300 milligrams. J-code billing units.